Search
for
Sort by
Research 31–60 of 389
- Chemotherapy and Cutaneous Drug Reactions
- Skin diseases in consequence of endocrine alterations
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Skin manifestations associated with systemic diseases – Part I
- Medical Dermatology
- Clinical features, therapeutic outcomes and recovery period of long COVID
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- CUTANEOUS T-CELL LYMPHOMA
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
- Adverse Cutaneous Reactions to Antipsychotics
- INTERFERONS IN DERMATOLOGY
- Aldesleukin
- High dose interferon treatment in chronic hepatitis C.
- ESCITALOPRAM
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- A novel mutation in the FERMT1 gene in a Spanish family with Kindler’s syndrome
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- The eosinophilia-myalgia syndrome
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Acne Vulgaris
- Mucocutaneous reactions to chemotherapy
- Female Pattern Hair Loss
- Cutaneous manifestations of systemic infection in children
- Tales of bugs, delusions of parasitosis, and what to do
- Multiple Autoimmune Syndrome With Alopecia Universalis and Immune Thrombocytopenic Purpura
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Follikelhormone
- Reporting on Adverse Clinical Events